Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elite Pharms Inc (ELTP)

Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elite Pharms Inc 165 LUDLOW AVENUE NORTHVALE NJ 07647 USA

www.elitepharma.com Employees: 68 P: 201-750-2646

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Elite Pharmaceuticals, Inc. primarily engages in researching, developing, licensing, manufacturing, and marketing proprietary drug delivery systems and products. Their drug delivery technology involves releasing a drug into the bloodstream or delivering it to a target site in the body over an extended period of time or at predetermined times.

Key Statistics

Overview:

Market Capitalization, $K 387,611
Enterprise Value, $K 383,571
Shares Outstanding, K 1,076,996
Float, K 921,693
% Float 85.58%
Short Interest, K 2,098
Short Float 0.19%
Days to Cover 1.47
Short Volume Ratio 0.30
% of Insider Shareholders 14.42%
% of Institutional Shareholders 0.01%

Financials:

Annual Sales, $ 84,040 K
Annual Net Income, $ -4,310 K
Last Quarter Sales, $ 36,320 K
Last Quarter Net Income, $ 13,700 K
EBIT, $ 45,400 K
EBITDA, $ 47,540 K

Growth:

1-Year Return -27.59%
3-Year Return 931.23%
5-Year Return 471.27%
5-Year Revenue Growth 367.15%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/14/25
Next Earnings Date 06/29/26
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year 200.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ELTP Ratios

Ratio
Price/Earnings ttm 39.31
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 47.93%
Return-on-Assets % 25.81%
Profit Margin % -5.13%
Debt/Equity 0.05
Price/Sales 5.04
Price/Cash Flow 22.92
Price/Book 5.27
Book Value/Share 0.06
Interest Coverage -0.94
60-Month Beta 0.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar